116 related articles for article (PubMed ID: 1471382)
21. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Witzel L; Gütz H; Hüttemann W; Schepp W
Aliment Pharmacol Ther; 1995 Feb; 9(1):19-24. PubMed ID: 7766739
[TBL] [Abstract][Full Text] [Related]
22. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Yukselen V; Yasa MH; Karaoglu AO
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
[TBL] [Abstract][Full Text] [Related]
23. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
[TBL] [Abstract][Full Text] [Related]
24. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Schepp W; Rehner M; Witzel L
Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
[TBL] [Abstract][Full Text] [Related]
25. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Hotz J; Plein K; Schönekäs H; Rose K
Scand J Gastroenterol; 1995 Feb; 30(2):111-5. PubMed ID: 7732331
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
27. Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
Vcev A; Vceva A; Kurbel S; Takac B; Stimac D; Ivandić A; Ostojić R; Barbir A; Hovat D; Mihaljević S
Wien Klin Wochenschr; 2001 Dec; 113(23-24):939-41. PubMed ID: 11802510
[TBL] [Abstract][Full Text] [Related]
28. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of duodenal ulcer with pantoprazole. A multicenter study].
Fric P; Huslarová A; Dítĕ P; Jirásek V; Roth Z; Svoboda J; Drazná E; Dufek V; Dvorák M; Kunovská M; Münzová H; Pelech T; Petrtýl J; Zádorová Z; Zavoral M
Cas Lek Cesk; 1996 Dec; 135(23):758-61. PubMed ID: 9005122
[TBL] [Abstract][Full Text] [Related]
30. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR; Riff D; Humphries TJ
Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
[TBL] [Abstract][Full Text] [Related]
31. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
32. [Superiority of pantoprazole over ranitidine in the treatment of duodenal ulcer. Mexican clinical experience. Mexican Study Group of Pantoprazole++ in Duodenal Ulcer].
Dibildox M; Rose K; Tomás-Pons J; Fischer R; Gallo S
Rev Gastroenterol Mex; 1996; 61(3):193-8. PubMed ID: 9102740
[TBL] [Abstract][Full Text] [Related]
33. Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration--a multicentre study.
Rehner M; Rohner HG; Schepp W
Aliment Pharmacol Ther; 1995 Aug; 9(4):411-6. PubMed ID: 8527617
[TBL] [Abstract][Full Text] [Related]
34. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
35. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
[TBL] [Abstract][Full Text] [Related]
37. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
38. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD
Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
[TBL] [Abstract][Full Text] [Related]
40. Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
Bardhan KD; Cherian P; Bishop AE; Polak JM; Romanska H; Perry MJ; Rowland A; Thompson M; Morris P; Schneider A; Fischer R; Ng W; Lühmann R; McCaldin B
Am J Gastroenterol; 2001 Jun; 96(6):1767-76. PubMed ID: 11419827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]